Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Lyophilized (unreconstituted) storage Store unreconstituted glow stack vials at -20C (-4F) or lower in dry, dark conditions
It helps neutralize the most harmful free radicals without interfering with the beneficial ones
(2000), Horm Res 53(Suppl 3), PubMed 10971106 Statistics from preclinical literature AOD-9604 = modified fragment of hGH 177191 + N-terminal Tyr (sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe), molecular weight 1815.1 Da Developed at Metabolic Pharmaceuticals (Australia) based on the work of professor Frank Ng (Monash University) in the 1990s Standard experimental dose in obesity clinical trials: 1 mg/day subcutaneously (Phase 2b, Heffernan et al.) Mechanism: stimulation of 3-adrenergic receptors in adipose tissue, increased lipolysis and fatty acid oxidation without activation of the hGH receptor (no IGF-1 increase) Phase 2b clinical trial (2007, 300 patients): weight reduction ~2.8 kg vs placebo over 12 weeks FDA status: NDI rejection (2014) as a dietary supplement
Mutagenic TLS has been widely reported in cases where the patient has been undergoing treatment with DNA-damaging agents [111]
These core biological functions form the scientific foundation of glutathione benefits for skin, immunity, and overall cellular health
US$ 21.88
US$ 21.40
US$ 24.52
US$ 29.14
US$ 27.17
